Varinder Jeet

Research Outputs

Research Output per year

2008 2020

• 956 Citations
• 10 h-Index
• 14 Meeting abstract
• 10 Article
• 4 Review article
• 1 Chapter

Research Output per year

Research Output per year

Search results

• 2020

  Targeted beta therapy of prostate cancer with ¹⁷⁷Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)

  Yeh, M. C., Tse, B. W. C., Fletcher, N. L., Houston, Z. H., Lund, M., Volpert, M., Stewart, C., Sokolowski, K. A., Jeet, V., Thurecht, K. J., Campbell, D. H., Walsh, B. J., Nelson, C. C. & Russell, P. J., 7 May 2020, In : EJNMMI Research. 10, 13 p., 46.

  Research output: Contribution to journal › Article

  Open Access

  File

  • Glypicans
  • Prostatic Neoplasms
  • Antibodies
  • Neoplasms
  • Therapeutics
  1 Citation (Scopus)

  3 Downloads (Pure)
• 2019

  Emergence of microRNAs as key players in cancer cell metabolism

  Subramaniam, S., Jeet, V., Clements, J. A., Gunter, J. H. & Batra, J., 1 Sep 2019, In : Clinical Chemistry. 65, 9, p. 1090-1101 12 p.

  Research output: Contribution to journal › Review article

  • MicroRNAs
  • Metabolism
  • Cells
  • Neoplasms
  • Tumors
  20 Citations (Scopus)

• Interleukin (IL)-22 from IL-20 subfamily of cytokines induces colonic epithelial cell proliferation predominantly through ERK1/2 pathway

  Moniruzzaman, M., Wang, R., Jeet, V., McGuckin, M. A. & Hasnain, S. Z., 15 Jul 2019, In : International Journal of Molecular Sciences. 20, 14, p. 1-17 17 p., 3468.

  Research output: Contribution to journal › Article

  Open Access

  File

  • interleukins
  • MAP Kinase Signaling System
  • Cell proliferation
  • Epithelial Cells
  • Cell Proliferation
  6 Citations (Scopus)

  8 Downloads (Pure)

• MicroRNA-3162-5p-mediated crosstalk between Kallikrein family members including prostate-specific antigen in prostate cancer

  Australian Prostate Cancer BioResource, Mating, F., Jeet, V., Srinivasan, S., Cristino, A. S., Panchadsaram, J., Clements, J. A. & Batra, J., Jun 2019, In : Clinical Chemistry. 65, 6, p. 771-780 10 p.

  Research output: Contribution to journal › Article

  Open Access
  6 Citations (Scopus)
• 2018

  A biomarker and a therapeutic target: investigating the role of glypican-1 in prostate cancer

  Jeet, V., Rockstroh, A., Yeh, M-C., Campbell, D. H., Walsh, B. J., Russell, P. J. & Nelson, C. C., Aug 2018, In : BJU International. 122, S2, p. 36-37 2 p., 084.

  Research output: Contribution to journal › Meeting abstract

• Allele specific regulation of PDK1 by miRNAs in prostate cancer

  Subramaniam, S., Jeet, V., Walpole, C., Nelson, C. C., Gunter, J. H., Clements, J. A. & Batra, J., Aug 2018, In : BJU International. 122, S2, p. 36-36 1 p., 083.

  Research output: Contribution to journal › Meeting abstract

• A plasma biomarker panel of four microRNAs for the diagnosis of prostate cancer

  Australian Prostate Cancer BioResource, Matin, F., Jeet, V., Moya, L., Selth, L. A., Chambers, S., Clements, J. A. & Batra, J., Aug 2018, In : BJU International. 122, S2, p. 29-29 1 p., 066.

  Research output: Contribution to journal › Meeting abstract

  5 Citations (Scopus)

• A Plasma biomarker panel of four MicroRNAs for the diagnosis of prostate cancer

  Australian Prostate Cancer BioResource, Matin, F., Jeet, V., Moya, L., Selth, L. A., Chambers, S., Clements, J. A. & Batra, J., 27 Apr 2018, In : Scientific Reports. 8, 15 p., 6653.

  Research output: Contribution to journal › Article

  Open Access

  File
  27 Citations (Scopus)

  2 Downloads (Pure)

• Targeted beta therapy of human prostate cancer in vivo with Lu-177 labelled MIL-38 antibody against glypican-1 (GPC-1)

  Yeh, M-C., Tse, B. W. C., Fletcher, N. L., Huston, Z. H., Stewart, C., Sokolowski, K., Jeet, V., Wissmueller, S., Thurecht, K. J., Campbell, D. H., Walsh, B. J., Nelson, C. C. & Russell, P. J., Aug 2018, In : BJU International. 122, S2, p. 34-35 2 p., 078.

  Research output: Contribution to journal › Meeting abstract

• Targeted beta therapy of human prostate cancer in vivo with Lu-177 labelled Miltuximab textregistered antibody against glypican-1 ( GPC-1 )

  Yeh, M-C., Tse, B. W. C., Fletcher, N. L., Huston, Z. H., Stewart, C., Sokolowski, K., Jeet, V., Thurecht, K. J., Campbell, D. H., Walsh, B. J., Nelson, C. C. & Russell, P. J., Aug 2018, In : BJU International. 122, S2, p. 34-35 2 p., 78.

  Research output: Contribution to journal › Meeting abstract

  Open Access

  • Glypicans
  • Prostatic Neoplasms
  • Antibodies
  • Neoplasms
  • Lutetium
• 2017

  MicroRNAs in HPV associated cancers: small players with big consequences

  Satapathy, S., Batra, J., Jeet, V., Thompson, E. W. & Punyadeera, C., 3 Jul 2017, In : Expert Review of Molecular Diagnostics. 17, 7, p. 711-722 12 p.

  Research output: Contribution to journal › Review article
  16 Citations (Scopus)

• PDK1 dependent aerobic glycolysis and tumorigenesis in prostate cancer is regulated by miRNAs in an allele dependent manner

  Subramaniam, S., Jeet, V., Walpole, C., Nelson, C. C., Gunter, J. H., Clements, J. A. & Batra, J., Aug 2017, In : BJU International. 120, S1, p. 19-19 1 p., 014.

  Research output: Contribution to journal › Meeting abstract
• 2016

  Comprehensive profiling of androgen signalling and energy and lipid metabolism highlights heterogeneity of prostate cancer cell lines

  Sadowski, M. C., Mcpherson, S. J., Rockstroh, A., Soekmadji, C., Tevz, G., Gunter, J. H., Jeet, V. & Nelson, C. C., Aug 2016, In : BJU International. 118, S1, p. 34-34 1 p., 085.

  Research output: Contribution to journal › Meeting abstract

• Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsets

  Chiang, M-C., Tullett, K. M., Lee, Y. S., Idris, A., Ding, Y., McDonald, K. J., Kassianos, A., Rojas, I. M. L., Jeet, V., Lahoud, M. H. & Radford, K. J., Feb 2016, In : European Journal of Immunology. 46, 2, p. 329-339 11 p.

  Research output: Contribution to journal › Article
  28 Citations (Scopus)

• Glypican-1: a new biomarker for the detection of prostate cancer

  Yeh, M-C., Jeet, V., Wissmueller, S., Campbell, D. H., Walsh, B. J., Nelson, C. C. & Russell, P. J., Aug 2016, In : BJU International. 118, S1, p. 27 1 p., 038.

  Research output: Contribution to journal › Meeting abstract

• Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer

  Tevz, G., McGrath, S., Demeter, R., Magrini, V., Jeet, V., Rockstroh, A., McPherson, S., Lai, J., Bartonicek, N., An, J., Batra, J., Dinger, M. E., Lehman, M. L., Williams, E. D. & Nelson, C. C., 15 Jan 2016, In : Molecular and Cellular Endocrinology. 420, p. 159-168 10 p.

  Research output: Contribution to journal › Article
  10 Citations (Scopus)

• MicroRNAs in plasma: potential minimally invasive biomarkers for the detection of aggressive prostate cancer

  Matin, F., Moya, L., Jeet, V., Clements, J. & Batra, J., Aug 2016, In : BJU International. 118, S1, p. 30-30 1 p., 046.

  Research output: Contribution to journal › Meeting abstract

  14 Citations (Scopus)

• MicroRNA theranostics in prostate cancer precision medicine

  Matin, F., Jeet, V., Clements, J. A., Yousef, G. M. & Batra, J., Oct 2016, In : Clinical Chemistry. 62, 10, p. 1318-1333 16 p.

  Research output: Contribution to journal › Review article
  28 Citations (Scopus)

• More than a biomarker: exploring the role of glypican-1 as a new therapeutic target for prostate cancer

  Jeet, V., Yeh, M-C., Campbell, D. H., Walsh, B. J., Russell, P. J. & Nelson, C. C., Aug 2016, In : BJU International. 118, S1, p. 28 1 p., 040.

  Research output: Contribution to journal › Meeting abstract
• 2015

  Impeding the adaptive response of prostate cancer to androgen targeted therapies with relaxin receptor antagonist

  Tevz, G., Hossain, A. M., Bock, N., Jeet, V., Bathgate, R. A., Williams, E. D., Lehman, M., Hutmacher, D. W., Wade, J. D. & Nelson, C. C., Aug 2015, In : BJU International. 116, S1, p. 36-36 1 p., 075.

  Research output: Contribution to journal › Meeting abstract

  9 Citations (Scopus)

• Investigating the role of a potential angiogenic target, YKL40, for the treatment of metastatic prostate cancer

  Jeet, V., Rockstroh, A., Lehman, M. & Nelson, C. C., Aug 2015, In : BJU International. 116, S1, p. 33-33 1 p., 063.

  Research output: Contribution to journal › Meeting abstract
• 2014

  Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells

  Jeet, V., Tevz, G., Lehman, M., Hollier, B. & Nelson, C., Oct 2014, In : Endocrine-Related Cancer. 21, 5, p. 723-737 15 p.

  Research output: Contribution to journal › Article

  Open Access

  File
  15 Citations (Scopus)

  12 Downloads (Pure)

• Therapeutic options for metastatic castration resistant prostate cancer: has the situation improved?

  Jeet, V., 2014, Advances in Drug Resistance Research. Morais, C. (ed.). New York: Nova Science Publishers, p. 137-154 15 p. (Public health in the 21st century).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Castration
  • Prostatic Neoplasms
  • Radium
  • Androgens
  • Therapeutics
• 2013

  YKL40as a therapeutic target for the treatment of metastatic Prostate Cancer

  Jeet, V. & Nelson, C. C., Aug 2013, In : BJU International. 112, S1, p. 45-45 1 p., 25038.

  Research output: Contribution to journal › Meeting abstract

  22 Citations (Scopus)
• 2012

  Cross-presentation by human dendritic subsets depends on the type of antigen and exogenous stimuli

  McDonald, K., Kassianos, A., Jeet, V., Ju, X., Ding, Y., Hart, D. & Radford, K., May 2012, In : Molecular Immunology. 51, 1, p. 28-28 1 p.

  Research output: Contribution to journal › Meeting abstract

• Targeting Aurora Kinases: A novel approach to curb the growth & chemoresistance of androgen refractory prostate cancer

  Jeet, V., Russell, P. J., Verma, N. D. & Khatri, A., 1 Feb 2012, In : Current Cancer Drug Targets. 12, 2, p. 144-163 20 p.

  Research output: Contribution to journal › Article

  • Aurora Kinase A
  • Androgens
  • Prostatic Neoplasms
  • docetaxel
  • Growth
  4 Citations (Scopus)
• 2010

  Human CD141⁺ (BDCA-3)⁺ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens

  Jongbloed, S. L., Kassianos, A. J., McDonald, K. J., Clark, G. J., Ju, X., Angel, C. E., Chen, C-J. J., Dunbar, P. R., Wadley, R. B., Jeet, V., Vulink, A. J. E., Hart, D. N. J. & Radford, K. J., 7 Jun 2010, In : Journal of Experimental Medicine. 207, 6, p. 1247-1260 14 p.

  Research output: Contribution to journal › Article

  Open Access

  File
  702 Citations (Scopus)

  9 Downloads (Pure)

• Modeling prostate cancer: a perspective on transgenic mouse models

  Jeet, V., Russell, P. J. & Khatri, A., Mar 2010, In : Cancer and Metastasis Reviews. 29, 1, p. 123-142 20 p.

  Research output: Contribution to journal › Review article
  34 Citations (Scopus)
• 2008

  Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer

  Jeet, V., Ow, K., Doherty, E., Curley, B., Russell, P. J. & Khatri, A., 1 Apr 2008, In : Prostate. 68, 5, p. 548-562 15 p.

  Research output: Contribution to journal › Article
  9 Citations (Scopus)